RTI Surgical Inc : Wired News – RTI Surgical Commercially Launches Fortilink(R)-TS and -L IBF Systems with TETRAfuse 3D Technology
Stock Monitor: EDAP TMS Post Earnings Reporting
LONDON, UK / ACCESSWIRE / June 14, 2018 / If you want access to our free research report on RTI Surgical, Inc. (NASDAQ: RTIX), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=RTIX as the Company's latest news hit the wire. On June 12, 2018, the Company announced that it has commercially launched Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology. The Fortilink-TS and -L Systems are intended for use in lumbar interbody fusion procedures at one or two adjoining levels in patients with degenerative disc disease. Register today and get access to over 1,000 Free Research Reports by joining our site below:
Active-Investors.com is currently working on the research report for EDAP TMS S.A. (NASDAQ: EDAP), which also belongs to the Healthcare sector as the Company RTI Surgical. Do not miss out and become a member today for free to access this upcoming report at:
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, RTI Surgical most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:
Fortilink-L IBF System is Designed to Participate in Fusion without Compromising Mechanical Integrity or Radiographic Visibility
The Fortilink-L IBF System is intended for a lateral transpsoas approach to the lumbar spine, also known as lateral lumbar interbody fusion (LLIF) surgeries. The Fortilink-TS System is intended for traditional posterior approaches known as transforaminal lumbar interbody fusion (TLIF) or bilateral posterior lumbar interbody fusion (PLIF) surgeries. TETRAfuse 3D Technology features a nano-rough surface with antibacterial characteristics, and is designed to participate in fusion without compromising mechanical integrity or radiographic visibility.
Fortilink-L System is the First Osteointegrative, Radiolucent Cage
Joseph O'Brien, Founder of the Washington Spine & Scoliosis Institute at OrthoBethesda, and one of the first surgeons to implant the Fortilink-L device, stated that the Fortilink-L System is the first osteointegrative, radiolucent cage. O'Brien added that while other companies are focusing on titanium, TETRAfuse 3D Technology offers ingrowth features that help the implant to fully integrate with the fusing bone. It also has best-in-class X-ray compatibility, which allows to track patients' progress with more confidence.
RTI Surgical Launched its First Implant Using TETRAfuse 3D Technology in October 2017
On October 25, 2017, the Company commercially launched Fortilink-C IBF System with TETRAfuse® 3D Technology. The Fortilink-C system is the first in a family of devices to incorporate RTI Surgical's TETRAfuse 3D Technology. The Fortilink-C IBF System is the first 3D printed polymer-based, cervical interbody device to incorporate macro, micro, and nano-rough features on the entire implant surface, not just on the endplate surfaces. The Fortilink-C device is designed to allow bony ingrowth on all implant surfaces while maintaining radiolucent and bone-like mechanical properties that surgeons expect.
All Fortilink implants have received 510(k) clearance from the US Food and Drug Administration (FDA).
About TETRAfuse 3D Technology
TETRAfuse 3D Technology is the first 3D printed polymer-based interbody fusion device to incorporate a nano-rough surface that has demonstrated, in a pre-clinical study, more notable trabecular bone ingrowth compared to PEEK and titanium-coated PEEK. TETRAfuse 3D Technology was developed to offer surgeons an interbody material that participates in the fusion process while maintaining bone-like mechanical properties and radiolucent imaging.
About Degenerative Disc Disease (DDD)
DDD describes the natural breakdown of an intervertebral disc of the spine. DDD is not considered a disease, nor is it progressively degenerative. On the contrary, disc degeneration is often the effect of natural daily stresses and minor injuries that cause spinal discs to gradually lose water as the anulusfibrosus, or the rigid outer shell of a disc, weakens. As discs weaken and lose water, they begin to collapse. This can result in pressure being put on the nerves in the spinal column, causing pain and weakness.
About RTI Surgical, Inc.
Headquartered in Alachua, Florida, RTI Surgical is a leading global surgical implant organization providing surgeons with safe biologic, metal, and synthetic-based implants around the world. RTI Surgical's implants are used in sports medicine, general surgery, spine, orthopedic, and trauma procedures, and are distributed in nearly 50 countries. RTI Surgical has four manufacturing facilities throughout the US and Europe.
Stock Performance Snapshot
June 13, 2018 - At Wednesday's closing bell, RTI Surgical's stock dropped 2.08%, ending the trading session at $4.70.
Volume traded for the day: 115.84 thousand shares, which was above the 3-month average volume of 108.95 thousand shares.
Stock performance in the last month ? up 4.44%; previous six-month period ? up 8.05%; and year-to-date - up 14.63%
After yesterday's close, RTI Surgical's market cap was at $298.12 million.
Price to Earnings (P/E) ratio was at 114.63.
The stock is part of the Healthcare sector, categorized under the Medical Appliances & Equipment industry. This sector was flat at the end of the session.
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia